Item 8.01. Other Events.
Pursuant to Pfizer Inc.'s ("Pfizer") and Wyeth's ("Wyeth") obligations under
Rule 14e-2 under the Securities Exchange Act of 1934, on May 22, 2020, Pfizer
issued a press release announcing that it and Wyeth recommend rejection of the
unsolicited tender offer made by Huguenot Bond Liquidity, LLC on May 11, 2020
(as amended and restated on May 21, 2020) to purchase up to $162.5 million
principal amount of Pfizer's outstanding 7.200% notes due 2039 and up to
$130.0 million principal amount of Wyeth's 5.950% notes due 2037. Wyeth is a
wholly-owned subsidiary of Pfizer.
A copy of the press release is attached hereto as Exhibit 99.1 to this Form 8-K
and is incorporated by reference to this Item 8.01 as if fully set forth herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
99.1 Press release issued by Pfizer Inc. on May 22, 2020
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses